Important information COVID-19

Congress Now Virtual

New date : August 20-23, 2020

Sunday August 23, Barcelona

01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting room 133‑134
DENOSUMAB discontinuation: Trends, challenges, ups-and-downs
Chairperson: Bruno Muzzi Camargos
Vertebral Fracture Following D-Mab Discontinuation: Supporting Data Oscar Rosero Olarte
Pathophysiology Of The Osteoclastic “Flare” After Discontinuation Adriana Medina Orjuella
Biochemichal And Imaging Assessment: Ups And Downs Bruno Muzzi Camargos
Bone Loss After D-Mab Discontinuation In 150 Patients Maria Belen Zanchetta
D-Mab Patient Management In The Clinical Setting: Stepping On The Right Foot Luis Fernando Vidal Neira
Meeting room 118
When a DXA is indicated, a VFA is also recommended
Chairpersons: Willem Lems, Kristina Åkesson
Introduction Willem Lems
Clinical relevance of vertebral fractures Julien Paccou
Radiological diagnosis of vertebral fractures with VFA Jean Zhang
Advantages and limitations of VFA Manju Chandran
Discussion Kristina Åkesson
Meeting room 119
Fragility fractures in Sub-Saharan Africa: Time to break the myth!
Chairperson: Celia L. Gregson
Chairs introduction and setting the scene Kate Ward
Trends in fracture incidence in high-income countries Bo Abrahamsen
Breaking the myth in Sub-Saharan Africa – what do we know about fragility fracture? Kate Ward
Panel discussion
Summary and wrap-up Kate Ward
Meeting room 122
Female Bone Health: a gynecological approach on women's special conditions
Chairperson: Adriana Orcesi Pedro
Opening Adriana Orcesi Pedro
Update on management of low bone mass in young women Adriana Orcesi Pedro
Bone mass and fracture risk during pregnancy and lactation Ben‑Hur Albergaria
Evaluation and management of osteopenia and osteoporosis in breast and gynecological cancer survivors Marcelo Luis Steiner
Question & Answers with audience
Meeting room 123
Sarcopenic obesity
Chairperson: Ifigenia Kostoglou‑Athanassiou
Sarcopenia. Diagnosis and evaluation Panagiotis Athanassiou
Sarcopenia and nutrition Lambros Athanassiou
Sarcopenic obesity. Definition and pathophysiology Ifigenia Kostoglou‑Athanassiou
Sarcopenic obesity. Management Yannis Dionyssiottis
Discussion
Meeting room 130
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 1: Defining Frailty
Chairperson: Dominique Verté
Introduction Ivan Bautmans
Towards a uniform language of Frailty Roberta Vella‑Azzopardi
Fatigue in the frailty constructs Veerle Knoop
The disability paradox in the frailty constructs Axelle Costenoble
Measures of cognition in the frailty constructs Mirko Petrovic
Discussion
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
Meeting room 124‑125
Assessment of cardio-vascular safety of anti-osteoporosis medications. Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: Adolfo Diez‑Perez, Nicholas R. Fuggle
Welcome and scope of the problem Adolfo Diez‑Perez
Assessment of cardio-vascular safety of Calcium and Vitamin D Nicholas Harvey
Assessment of cardio-vascular safety of menopausal hormonal therapy and SERMs Santiago Palacios
Assessment of cardio-vascular safety of peptides and monoclonal antibodies used as a treatment for osteoporosis René Rizzoli
Discussion (Leader: Santiago Palacios): All participants of the Working Group
Conclusions Nicholas R. Fuggle
Panel: Maria Luisa Brandi, Antonio Cano, Cyrus Cooper, Elaine M. Dennison, Adolfo Diez‑Perez, Nicholas R. Fuggle, Nicholas Harvey, John A. Kanis, Jean‑Marc Kaufman, Santiago Palacios, Daniel Prieto‑Alhambra, Jean‑Yves Reginster, René Rizzoli, Serge Rozenberg, Thierry Thomas, Florence Trémollières
08.00 - 09.00
Meeting room 131‑132
ESPRM-ESCEO-IOF Joint Session
Meeting room 131‑132
Fibromyalgia : An evidence-based approach for diagnosis and management
Chairperson: Fitnat Dincer
Update in Diagnosis of Fibromyalgia on the basis of Evidence Based Medicine Andreas Winkelman
Update in Pharmacological Management of Fibromyalgia on the Basis of Evidence Based Medicine Fitnat Dincer
Update in Non-Pharmacological Management of Fibromyalgia on the Basis of Evidence Based Medicine Raquel Valero, Susana Munoz
08.00 - 09.00
Meeting room 120
Educational Lecture
‣ Behavioral strategies for the busy clinician
Daniel Pinto
08.00 - 09.00
Meeting room 121
Educational Lecture
‣ Vascular calcification and bone fragility: Links beyond the ageing
Jorge Cannata Andia
09.00 - 10.00
MEET-THE-EXPERT SESSIONS
Meeting room 127‑128
Bariatric surgery, bone and joints
Daniel Prieto‑Alhambra
Meeting room 131‑132
Androgens, bone and muscles
Jean‑Marc Kaufman
Meeting room 133‑134
Efficacy and cost/benefit of FLS
Radmila Matijevic
Meeting room 118
High Bone Mass: What are the causes and how should we manage it?
Celia L. Gregson
Meeting room 119
Local Bone Treatment in Osteoporosis (supported by an Unrestricted Educational Grant from Agnovos Healthcare)
Andreas Kurth
09.00 - 10.00
Poster Area
Poster Viewing Session III
10.00 - 12.00
Auditorium A
SCIENTIFIC SESSION VII
Chairpersons: Famida Jiwa, Serge Ferrari
10.00
Auditorium A
Plenary Lecture 9
Rare bone diseases : what do they teach us for musculoskeletal disorders management Kassim Javaid
10.30
Auditorium A
Presentation of the ESCEO-IOF Young Investigator Awards
Cyrus Cooper
10.40
Auditorium A
Oral communication selected from abstracts
10.40
Auditorium A
OC35
‣ OSTEOGENESIS IMPERFECTA: FRACTURE CHARACTERISTICS DURING PREGNANCY AND POST-PARTUM
Presenting author: E. Koumakis
Authors: A. Dellal, M. Debernardi, B. Cortet, F. Debiais, R. M. Javier, T. Thomas, N. Mehsen, M. Cohen‑Solal, E. Fontanges, M. Laroche, C. Marcelli, K. Briot, C. Roux, C. Cormier
10.50
Auditorium A
OC36
‣ TREATMENT INITIATION RATE POST HIP FRACTURE AS A KEY INDICATOR IN AN ORTHOPAEDIC FRACTURE LIAISON SERVICE
Presenting author: J. Delisle
Authors: B. Benoit, G. Y. Laflamme, S. Leduc, H. Nguyen, P. Ranger, J. Fernandes
11.00
Auditorium A
OC37
‣ PHYSICAL PERFORMANCE TRAJECTORIES AND MORTALITY AMONG NURSING HOME RESIDENTS: THE RESULTS OF THE SENIOR COHORT
Presenting author: A. Charles
Authors: J. Detilleux, F. Buckinx, J.‑Y. Reginster, B. Gruslin, O. Bruyère
11.10
Auditorium A
OC38
‣ LIFESTYLE, ANTHROPOMETRY, AND BONE HEALTH ACROSS THREE GENERATIONS OF THE HERTFORDSHIRE COHORT STUDY
Presenting author: S. Carter
Authors: C. Parsons, M. O’breasail, K. Ward, C. Cooper, N. C. Harvey, E. M. Dennison, M. A. Clynes
11.20
Auditorium A
OC39
‣ THE DIFFERENT DIAGNOSIS CRITERIA OF THE EWGSOP2 DEFINITION AND LONG-TERM CLINICAL OUTCOMES
Presenting author: C. Beaudart
Authors: M. Locquet, L. Lengelé, J.‑Y. Reginster, O. Bruyère
11.30
Auditorium A
Plenary Lecture 10
Strategies to fill the Treatment Gap in Osteoporosis: place of Combination and Sequential Regimens Manju Chandran
12.00 - 13.00
NON-SPONSORED SYMPOSIA
Meeting room 124‑125
Clinical diagnostics of chronic and acute pain. Multimodal approach
Chairperson: Olga Kurushina
Acute and chronic pain: The difference between diagnostic approaches Olga Kurushina
Pain and biomechanics Alexander Barulin
Features of clinical diagnosis of cervicogenic headache Anna Drushlyakova
Diagnosis of temporomandibular disorders in patients with chronic facial pain Bogdan Kalinchenko
Meeting room 127‑128
Awareness, Risk factors and Early Detection of Osteoporosis in Turkish Postmenopausal Female Patients
Chairpersons: Pinar Borman, Vesile Sepici
The Awareness and Knowledge of Osteoporosis and Risk factors in a group Turkish Geriatric Patients Belgin Karaoglan
The Knowledge about Osteoporosis in a Group of Turkish Females: Relationship with Quantitative Ultrasonographic Scores Pinar Borman
Laboratory overview of bone turnover markers Aylin Sepici Dincel
Risk Factors of osteoporosis and osteoporotic fractures Vesile Sepici
Meeting room 131‑132
Controversies regarding the management of gout and asymptomatic hyperuricemia
Chairperson: Razvan Adrian Ionescu
Uric acid - Friend or foe? Mihai Bojinca
Asymptomatic hyperuricemia - The hidden realm (Imaging clue) Florentin Ananu Vreju
Bone mineral density in hyperuricemia and gout - Collateral damage? Claudiu Avram
Gout treatment - As easy as it seems? Razvan Adrian Ionescu
Meeting room 133‑134
The microcirculation abnormalities in osteoporosis and osteoarthritis
Chairpersons: Sekib Sokolovic, Alena Rudenko
Introduction Sekib Sokolovic
Angiogenesis and Bone Gerold Holzer
Vascular pathology and Osteoarthritis, Imaging of Microcirculation Juan Jose Scali
The Microcirculation abnormalities in Osteoporosis and Osteoarthritis Sekib Sokolovic
Discusion and Closing remarks
Meeting room 118
Non-pharmacological approaches in the management of osteoporosis
Chairperson: Yesim Gokce Kutsal
How to modify life-style? Yesim Gokce Kutsal
The role of exercises: What type of exercise when? Jale Meray
Are orthoses and physical modalities effective for osteoporosis and/or osteoporotic fractures? Ayse A. Kucukdeveci
Case presentations Yesim Kirazli
Meeting room 119
Relevance of body composition in chronic diseases
Chairperson: Mislav Radić
Association of body composition with disease activity in rheumatoid arthritis Mislav Radić
Relationship of body composition with osteoporosis Tonko Vlak
Impact of disability on body composition in multiple sclerosis Ozren Polasek
Meeting room 120
Osteosarcopenia school
Chairpersons: Mark Lissens, Yannis Dionyssiotis
Osteosarcopenia Ifigenia Kostoglou‑Athanassiou
Neurogenic osteoporosis due to sarcopenia in post poliomyelitis patients Mark Lissens
Osteosarcopenia school Yannis Dionyssiotis
Discussion
Meeting room 121
The Brussels study on the early predictors of frailty (BUTTERFLY) – part 2: First results from the BUTTERFLY study
Chairperson: Dominique Verté
Introduction Ivan Bautmans
General profile of the Butterfly participants Aziz Debain
Validated equations for estimating body composition in the oldest old Jona Van den Broeck
Immunosenescence signatures in pre-frailty Rose Njemini
Discussion